Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01865032 · ClinicalTrials.gov registry record
Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis
A clinical trial, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- 150
- Enrollment target
NCT01865032 is a clinical trial that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 150 participants.
The verdict
NCT01865032 has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study is a single-site trial assessing the specificity of CL Detect™ Rapid Test versus the gold standard for Leishmania diagnosis in the US which is microscopic identification of Leishmania amastigotes in a stained lesion sample.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01865032
The ClinicalTrials.gov registry entry for NCT01865032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01865032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01865032 about?
NCT01865032 is a clinical study titled "Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis". This study is a single-site trial assessing the specificity of CL Detect™ Rapid Test versus the gold standard for Leishmania diagnosis in the US which is microscopic identification of Leishmania amastigotes in a stained lesion sample.
What is the current status of trial NCT01865032?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2013-06. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01865032?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.